Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Accumulated Expenses (2020 - 2025)

IceCure Medical (ICCM) has disclosed Accumulated Expenses for 5 consecutive years, with $46000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Expenses fell 96.62% to $46000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $46000.0, a 96.62% decrease, with the full-year FY2024 number at $46000.0, down 96.62% from a year prior.
  • Accumulated Expenses was $46000.0 for Q4 2024 at IceCure Medical, down from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.9 million in Q4 2021 to a low of $46000.0 in Q4 2024.
  • A 5-year average of $1.8 million and a median of $1.6 million in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: grew 2.1% in 2021, then crashed 96.62% in 2024.
  • IceCure Medical's Accumulated Expenses stood at $2.9 million in 2020, then grew by 2.1% to $2.9 million in 2021, then crashed by 45.8% to $1.6 million in 2022, then dropped by 13.8% to $1.4 million in 2023, then plummeted by 96.62% to $46000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Accumulated Expenses are $46000.0 (Q4 2024), $1.4 million (Q4 2023), and $1.6 million (Q4 2022).